Skip to main content
Top
Published in: Supportive Care in Cancer 5/2018

01-05-2018 | Letter to the editor

Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results

Authors: G. Fabbrocini, M. C. Annunziata, M. Donnarumma, S. Cacciapuoti, C. Marasca, A. Tosti

Published in: Supportive Care in Cancer | Issue 5/2018

Login to get access

Excerpt

Dear Editor, …
Literature
5.
go back to reference Panariello L, Caro G, Bianca D, Fabbrocini G (2015) Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas. G Ital Dermatol Venereol 150(6):755–756PubMed Panariello L, Caro G, Bianca D, Fabbrocini G (2015) Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas. G Ital Dermatol Venereol 150(6):755–756PubMed
6.
go back to reference Morton C, Szeimies RM, Sidoroff A, Wennberg AM, Basset-Seguin N, Calzavara-Pinton P, Gilaberte Y, Hofbauer G, Hunger R, Karrer S, Lehmann P, Piaserico S, Ulrich C, Braathen L, European Dermatology Forum (2015) European dermatology forum guidelines on topical photodynamic therapy. Eur J Dermatol 25(4):296–311PubMed Morton C, Szeimies RM, Sidoroff A, Wennberg AM, Basset-Seguin N, Calzavara-Pinton P, Gilaberte Y, Hofbauer G, Hunger R, Karrer S, Lehmann P, Piaserico S, Ulrich C, Braathen L, European Dermatology Forum (2015) European dermatology forum guidelines on topical photodynamic therapy. Eur J Dermatol 25(4):296–311PubMed
9.
go back to reference Xie Y, Wei ZB, Zhang Z, Wen W, Huang GW (2009) Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. Oncol Rep 22(6):1365–1371PubMed Xie Y, Wei ZB, Zhang Z, Wen W, Huang GW (2009) Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. Oncol Rep 22(6):1365–1371PubMed
Metadata
Title
Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results
Authors
G. Fabbrocini
M. C. Annunziata
M. Donnarumma
S. Cacciapuoti
C. Marasca
A. Tosti
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4056-x

Other articles of this Issue 5/2018

Supportive Care in Cancer 5/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine